NR4A1 and breast cancer: A set of data from Ontario Cancer Registry showed patients with age ≥ 65 years, positive hormonal receptors, stage I BC receive BCS followed by adjuvant RT + ET, adjuvant RT alone, adjuvant ET alone, or no adjuvant treatment.